Tools


Site Identifier

Österreich

Sitemap

Sitemap

Determination of FLC Kappa and Lambda in Cerebrospinal Fluid

Assay Validation in Patients with Suspected Multiple Sclerosis

Autor: Prof. Dr. W. Hübl
Wilhelminen Hospital
Vienna, Austria

Click to view webinar

Prof. Dr. Hübl presents results of a study aimed at understanding the capabilities of the Siemens FLC method for the determination of kappa free light chains (FLC) in cerebrospinal fluid as a possible diagnostic marker for multiple sclerosis. Using samples from 303 patients with various neurological diseases, FLC was measured in both serum and CSF using the Siemens FLC method as well as a competitor's FLC method on a Siemens BN ProSpec® System. View this informational webinar to learn more about this exploratory study.

Datum: 01.09.2014


Plasma Protein - Webinars

Note: Please consider N Latex FLC Kappa and N Latex FLC Lambda in vitro diagnostic reagents for the quantitative determination of free light chains (FLC), type kappa or lambda respectively, in human serum, heparinized plasma, EDTA plasma, and urine.

N Latex FLC Kappa and N Latex FLC Lambda are not intended for quantitative determination of free light chains in cerebrospinal fluid (CSF).Data and applications using CSF are not for use in diagnostic procedures.

War diese Information hilfreich für Sie?
Vielen Dank für Ihre Antwort
Wir haben Ziffern und/oder ein "@" Symbol in Ihrem Kommentar entdeckt. Wenn Sie von uns kontaktiert werden wollen, benützen Sie bitteunser Kontaktformular via Email. contact us

Anmerkung: Um eine persönliche Antwort zu erhalten kontaktieren Sie uns via Email

Vielen Dank